arrow_back View All Dates
6:00am EST
6:30am EST
7:00am EST
Novartis Breakfast Symposium (RSVP Event) Diamond Theatre – Prince George A
Poster Presentation Session: Traditional Surgery, Sustained Delivery, New Drugs, IOP Evaluation Cherry Blossom Lobby
PO047: Uveitic Glaucoma: A 10-year Retrospective and Risk Factors For Requiring Filtering Surgery Cherry Blossom LobbyDaniela Alvarez-Ascencio MD
PO048: Incidence of Corneal Transplant Graft Failure with Glaucoma Drainage Device Placed in the Anterior Chamber compared to the Ciliary Sulcus Cherry Blossom LobbyCara Capitena Young MD
PO049: Early Surgeon Experience with a New Valveless Glaucoma Drainage Device Cherry Blossom LobbyPeter Chang MD
PO050: Factors Associated with Trabeculectomy Failure Following Phacoemulsification Cherry Blossom LobbyPaul Cotran MD
PO051: Long-Term Outcomes of Primary Trabeculectomy Versus Combined Phacoemulsification-Trabeculectomy Using Automated Electronic Health Record Data Extraction Cherry Blossom LobbyJose Davila MD
PO052: The Relationship of Patient Distance to Postoperative Care on Follow-up Attrition and Glaucoma Surgery Outcomes. Cherry Blossom LobbyIan Funk BA
PO053: Direct Cyclopexy for Postraumatic Cyclodyalisis: Clinical Characteristics and Outcomes Cherry Blossom LobbyJorge Eduardo Gamiochipi Arjona MD
PO054: Ahmed Versus Baerveldt Glaucoma Drainage Device in Uveitic Glaucoma Cherry Blossom LobbyAllen Ganjei BS
PO055: Progression to No Light Perception Vision is Equally Likely with Valved and Non-Valved Tube Shunts in Neovascular Glaucoma Cherry Blossom LobbyAakriti Garg Shukla MD
PO056: Surgical Outcomes Assessment of Glaucoma Tube Shunt Implantation: an Electronic Health Records Analysis Cherry Blossom LobbyXinxing Guo MD PhD
PO057: Safety and Efficacy Outcomes of Modern Trabeculectomy with Low Dose Injected Mitomycin C with Planned Laser Suturelysis Cherry Blossom LobbySumeet Gupta MD
PO058: Three Year Outcomes of Trabecular Micro-Bypass Stents (iStent Inject) Stratified by Prior Glaucoma Surgery Cherry Blossom LobbyFritz Hengerer MD PHD
PO059: Diplopia in Patients with Baerveldt 250 and 350, and Ahmed FP7 Glaucoma Drainage Devices Cherry Blossom LobbyKhin Kilgore MD JD
PO060: The Requirement of Additional Glaucoma Surgery After Glaucoma Drainage Device Surgery in Patients with Open-angle, Angle-closure, Neovascular, and Pseudoexfoliative Glaucoma Cherry Blossom LobbyFelix Kung BA
PO061: Higher Rates of Recurrent Tube Exposure with Anti-VEGF Therapy in Patients with Macular Degeneration Cherry Blossom LobbyKaty Liu MD PHD
PO062: Predictive Factors for Microcystic Macular Edema in Glaucoma Cherry Blossom LobbyGolnoush Sadat Mahmoudi Nezhad MD-MPH
PO063: Risk Factors for Glaucoma Drainage Device Failure in the Pediatric Population Cherry Blossom LobbyCharles Medert MD
PO064: The Clinical Significance of Vertical Anterior Corneal Striae in Hypotony Cherry Blossom LobbyDelaram Mirzania BS
PO065: Effectiveness of a New Blebless Tube Shunt in Glaucomatous Eyes with Uncontrolled IOP Cherry Blossom LobbyMario Montelongo MD
PO066: Needle Revision of Filtering Bleb with Mitomycin C: Outcomes and Safety Profile Cherry Blossom LobbyNileema Patel BS
PO067: Intraocular Pressure Spikes After Cataract Surgery in Glaucoma and Non-glaucoma Patients Cherry Blossom LobbyFacundo Sanchez MD
PO068: The Steroid Response as a Contributor to the Hypertensive Phase After a Glaucoma Drainage Device Implant Cherry Blossom LobbyNoha Sherif BA
PO069: Effect of Phacoemulsification on Intraocular Pressure in African American Versus Caucasian Patients with Primary Open Angle Glaucoma Cherry Blossom LobbyAlexis Stefaniak BS
PO070: Does Tube-Iris Touch Cause Anterior Chamber Inflammation in Patients with Ahmed Valve Implantation? Cherry Blossom LobbySukhumal Thanapaisal MD
PO071: PAUL Glaucoma Implant in the Surgical Management of Refractory Glaucoma: 12-month Safety and Efficacy Outcomes of a Novel Aqueous Shunt Implant. Cherry Blossom LobbyGiacinto Triolo MD
PO072: Surgical Outcomes of Neovascular Glaucoma Cherry Blossom LobbySarah Wellik MD
PO073: Outcomes of Glaucoma Surgery Combined With Scleral Fixation of an Intraocular Lens Using Gore-Tex Suture Cherry Blossom LobbyAndrew Williams MD
PO074: Efficacy & Safety of Standalone Ab Interno Gelatin Microstent Implantation with MMC vs. Trabeculectomy with MMC: 3 Years Follow-Up Cherry Blossom LobbyPearson Wu MD
PO075: Quantitative Evaluation of Natural Drug therapy Options for Glaucoma: A Systematic Review and Meta-Analysis. Cherry Blossom LobbyKaren Allison MD
PO076: Development of an Injectable, Space-filling Thermosensitive Dydrogel as a Subconjunctival Bleb Scaffold and Sustained Release Drug Depot Cherry Blossom LobbyJames Armstrong HBSc PhD
PO077: Topical, Injectable and Implantable Slow Release Drug Delivery Platforms for Glaucoma Patients Cherry Blossom LobbyRamesh Ayyala MD
PO078: Intraocular Pressure Goals in Severe Secondary Glaucoma Cherry Blossom LobbyTrent Bowen MD
PO079: Long-Term IOP Lowering After A Single Bimatoprost SR Administration in a Phase 1/2 Study: Relationship to Early IOP Response Cherry Blossom LobbyJacob Brubaker MD
PO080: Factors Associated with Laser Trabeculoplasty Efficacy and Failure: IRIS Registry Analysis Cherry Blossom LobbyTa Chang MD
PO081: Effect of Bimatoprost SR on IOP in Patients Previously Treated With 0, 1, or ≥2 Topical IOP-Lowering Medications: Results of Phase 3 Study at Primary Database Lock Cherry Blossom LobbyE Randy Craven MD
PO082: Sources of Variability in Mean Intraocular Pressure (IOP) in Nonhuman Primates Instrumented with Continuous Telemetry Cherry Blossom LobbyJ Crawford Downs PhD
PO083: PROSE Devices in Glaucoma Patients Cherry Blossom LobbyAndrew Duong MSC
PO084: Engineering a Bioartificial Tenon’s Capsule Tissue Model for High Throughput Drug Testing Cherry Blossom LobbyMatthew Fung BSc
PO085: A Novel Injectable Intravitreal (IVT) Depot Formulation of a Beta-Adrenergic Prodrug as a Potential Sustained-Delivery Treatment in Primary Open Angle Glaucoma (POAG) Cherry Blossom LobbyBryan Hoang PhD
PO086: Comparison of Extraocular and Intraocular Pressure Transducers for Measurement of Transient IOP Fluctuations Using Continuous Wireless Telemetry Cherry Blossom LobbyJessica Jasien BS MSC
PO087: Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation Cherry Blossom LobbyQian Liu MD PHD
PO088: Patient Experience With Intraocular Pressure Measurement by Tonopen and Icare Cherry Blossom LobbyColleen Maturana MD
PO089: The Effects of Hypotension and Steep Trendelenburg Positioning on Optical Coherence Tomography Testing Cherry Blossom LobbyKristen Ann Mendoza MD
PO090: Profile of IOP Response to Bimatoprost Sustained-Release Implant (Bimatoprost SR) Before Added Treatment With Topical Medication: Phase 3 Study Results Cherry Blossom LobbyJonathan Myers MD
PO091: Safety and Effectiveness of Argon Laser Peripheral Iridoplasty (ALPI) in a Large Group of Narrow Angle Patients who Failed Laser Peripheral Iridotomy (LPI) Cherry Blossom LobbyAbraham Nirappel BS
PO092: Real-world use of Latanoprostene Bunod 0.024% in Patients with Glaucoma or Ocular Hypertension Naïve to Pharmacotherapy Cherry Blossom LobbyConstance Okeke MD MS
PO093: Incorporation of the First Nitric Oxide Donating Prostaglandin, Latanoprostene Bunod, into Clinical Practice Cherry Blossom LobbyJake Radell MA
PO094: Convolutional Neural Networks for Fast and Accurate Ophthalmic Medication Bottle Classification Cherry Blossom LobbyAlexander Richardson BS
PO095: Impact of Video Education on Patient Knowledge, Anxiety, and Satisfaction in Selective Laser Trabeculoplasty Cherry Blossom LobbyCason Robbins BS
PO096: Aqueous Humor Proteomic Changes Correlated with Visual Field Index Parameters in Glaucomatous Optic Neuropathy Cherry Blossom LobbyAshok Sharma PhD
PO097: Targeted Delivery via Intracameral Administration Versus Topical Dose of 14C-latanoprost in Animal Models. Cherry Blossom LobbyJie Shen PhD
PO098: Efficacy and Safety of Netarsudil 0.02% in Patients with Chronic Angle-closure Glaucoma Versus Primary Open-angle Glaucoma Cherry Blossom LobbyDaniel Lee MD
PO099: The Efficacy and Safety Profile of Latanoprostene Bunod 0.024% in Glaucoma Treatment: Real-World Outcomes Cherry Blossom LobbyMelih Ustaoglu MD
PO100: Intraocular Pressure Measurement Using Goldmann Applanation Aonometry by Ophthalmic Technicians - A Quality Improvement Initiative Cherry Blossom LobbyVarshini Varadaraj MD MPH
PO101: Bimatoprost Sustained-Release Implant (Bimatoprost SR) Responder Rates in Patients With Glaucoma or Ocular Hypertension: Phase 3 Study Results at Primary Database Lock Cherry Blossom LobbyMarina Bejanian PhD
PO102: The Effect of Topical Difluprednol on Intraocular Pressure in Patients with Uveitis Cherry Blossom LobbyMehmet Yakin MD
PO103: Tear Film Characteristics in Patients on Topical Glaucoma Therapy Cherry Blossom LobbyDaniel Yarmovsky BS
PO104: Changes in Intraocular Pressure and Angle Structures After Pupillary Dilation in Patients with Primary Angle Closure Suspect and Visually Significant Cataract Cherry Blossom LobbyMengya Zhao MD
Poster Viewing: Traditional Surgery, Sustained Delivery, New Drugs, IOP Evaluation Cherry Blossom Lobby
Registration Woodrow Wilson Lobby
8:00am EST
8:04am EST
8:05am EST
8:12am EST
8:17am EST
8:24am EST
8:29am EST
8:30am EST
8:36am EST
8:41am EST
8:48am EST
8:53am EST
9:00am EST
9:04am EST
9:05am EST
9:08am EST
9:18am EST
9:23am EST
9:26am EST
9:36am EST
9:41am EST
9:44am EST
9:54am EST
9:59am EST
10:02am EST
10:12am EST
10:17am EST
10:20am EST
10:30am EST
10:35am EST
10:59am EST
11:00am EST
11:09am EST
11:18am EST
11:27am EST
11:36am EST
11:45am EST
12:00pm EST
12:10pm EST
12:15pm EST
12:16pm EST
12:20pm EST
12:32pm EST
12:40pm EST
12:45pm EST
1:00pm EST
1:05pm EST
1:15pm EST
2:29pm EST
2:30pm EST
2:40pm EST
2:50pm EST
3:00pm EST
3:10pm EST
3:20pm EST
3:30pm EST
3:40pm EST
4:00pm EST
4:29pm EST
4:30pm EST
4:37pm EST
4:42pm EST
4:49pm EST
4:54pm EST
5:00pm EST
5:01pm EST
5:06pm EST
5:13pm EST
5:18pm EST
5:25pm EST
5:30pm EST
5:37pm EST
5:40pm EST
6:15pm EST
7:00pm EST
